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Abstract
We applied a linear-array-based photoacoustic probe to detect melanin-containing melanoma 
tumor depth and volume in nude mice in vivo. This system can image melanomas at five frames 
per second (fps), which is much faster than our previous handheld single transducer system (0.1 
fps). We first theoretically show that, in addition to the higher frame rate, almost the entire 
boundary of the melanoma can be detected by the linear-array-based probe, while only the 
horizontal boundary could be detected by the previous system. Then we demonstrate the ability of 
this linear-array-based system in measuring both the depth and volume of melanoma through 
phantom, ex vivo, and in vivo experiments. The volume detection ability also enables us to 
accurately calculate the rate of growth of the tumor, which is an important parameter in 
quantifying the tumor activity. Our results show that this system can be used for clinical 
melanoma diagnosis and treatment in humans at the bedside.
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Melanoma is the most serious form of skin cancer, and since the 1970's, the incidence of 
melanoma has increased markedly in fair-skinned populations living in industrialized 
countries [1]. Worldwide, it is now the 4th most common cancer in men and 5th most 
common cancer in women. In addition, it is estimated that the lifetime risk of developing 
melanoma for persons born in the year 2014 will be 1 in 50 [2]. Early diagnosis is the key, 
as melanoma is essentially curable if diagnosed when it is localized and non-invasive, but is 
fatal when metastatic. Currently, skin examination and recognition of gross lesion 
characteristics, followed by biopsy and histological examination of any suspicious lesions is 
the standard of care.
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In the clinical setting, pigmented lesions that are concerning for melanoma may oftentimes 
be partially biopsied (either by tangential or punch biopsy), particularly in the cosmetically 
sensitive areas of the faces, hands, or feet. In these instances, if a diagnosis of melanoma is 
made on partial biopsy, a provisional Breslow's depth may be reported, as only part of the 
tumor is available for microscopic evaluation. A recent study shows that approximately 14% 
of all melanoma specimens were partially biopsied, leading not only to significant 
misdiagnosis, but also to microstaging inaccuracy [3]. The same group had earlier 
demonstrated that in the hands of experienced dermatologists, accuracy of tumor depth by 
partial biopsy was achieved in only 88% of samples, which is unacceptable for appropriate 
patient management [4]. In addition, in the current health care environment, many patients 
with dermatologic disease will be seen by physicians instead of by dermatologists, and the 
use of physician extenders is increasing: all of these contribute to a current trend, recognized 
several years ago, of inadequate technique and biopsy size [5]. In sum, the surgeon is often 
faced with a treatment dilemma in the case of a partially biopsied melanoma — whether to 
plan a “definitive” surgery based upon a provisional measurement in the anticipation that the 
Breslow's depth measurement represents the thickest portion of the tumor, or perform an 
excisional biopsy of the entire remaining lesion to get an accurate measurement prior to 
definitive surgery [6]. Thus, in vivo imaging of melanomas to determine tumor depth could 
significantly aid melanoma patient management and alleviate the need for a second, 
excisional biopsy.
Current techniques for melanoma detection have various limitations [7]. High-frequency 
ultrasound can measure melanoma depth, but the image contrast is poor because the acoustic 
impedance difference between melanoma and surrounding tissues is small [8]. In distinction, 
optical methods, such as dermoscopy [9], confocal microscopy [10], and optical coherence 
tomography [11], employ high pigment contrast to facilitate melanoma detection, but the 
penetration is highly limited because these modalities work only in the optical ballistic 
regime. Other imaging modalities, such as magnetic resonance imaging (MRI) [12] and 
positron emission tomography [13], are also used in detection of melanoma metastasis, 
however their resolution is poor for the detection of small primary cutaneous tumors of the 
skin and they are not cost-effective. Thus, there is a need to develop an improved imaging 
technique for detection and characterization of melanoma in vivo.
Combining both optical contrast and acoustic penetration, photoacoustic (PA) tomography 
(PAT) has been successfully applied in cutaneous vasculature imaging in humans in vivo 
[14, 15]. In PAT, the target is first illuminated with a short laser pulse. Then the laser light is 
absorbed by the target, leading to a temperature rise and a subsequent initial pressure rise 
[16-21]. The pressure rise propagates as a photoacoustic wave and is finally detected by 
either a focused ultrasonic transducer or a transducer array. Because melanin has strong 
optical absorption over a broad spectrum, it can be detected by PAT with high contrast. 
Meanwhile, high resolution can be maintained in PAT because the photoacoustic wave has 
low scattering in tissue [22].
We recently reported that, in a murine xenograft melanoma model, tumor thickness can be 
accurately determined in vivo using a handheld photoacoustic probe [6]. In that study, a 
single ultrasonic transducer and a 10 Hz laser were employed, limiting the imaging speed to 
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around one frame per ten seconds. In addition, only the horizontal boundaries of the tumor 
could be detected due to the limited view angle of the focused transducer. To address these 
limitations, we next employed an ultrasonic transducer-array-based photoacoustic probe to 
detect melanoma depth, as described herein. The imaging speed can be increased to five 
frames per second by using a 20 Hz laser. Using this probe and employing the large 
acceptance angle of the transducer array in the imaging plane, nearly the entire perimeter of 
the melanoma could be assessed. Furthermore, by simply adding a one-dimensional 
scanning stage, three-dimensional (3D) measurements of the melanoma could be obtained 
while the small footprint and convenience of the handheld device are maintained. With its 
ability to detect the margins in 3 axes, the array-based probe can be further used to 
determine the volume of a melanoma. It has been proposed that, similar to other solid 
tumors, melanoma volume may prove to be an excellent prognostic indicator — probably 
superior to Breslow's depth [23]. In this manuscript, we first theoretically demonstrate that 
the linear-array-based probe can be used to determine and measure nearly the entire 
melanoma boundary, while the single ultrasonic transducer-based probe can detect only the 
horizontal boundary. Then we experimentally prove the ability of the linear-array-based 
probe to measure melanomas in phantoms, ex vivo, and in vivo.
Figure 1 shows a schematic of the linear-array-based photoacoustic probe for melanoma 
imaging. A linear-array transducer (LZ250, Visualsonics Inc.), with a central frequency of 
21 MHz and a 55% bandwidth, detected the photoacoustic signals [24]. The transducer array 
contained 256 elements, and had a size of 23 mm × 3 mm, as shown in Fig. 1. Each element 
of the array was cylindrically focused, and the focal length was 15 mm. A tunable optical 
parametric oscillator laser with a 20 Hz pulse repetition rate was the light source and was 
coupled into an optical fiber bundle. In our experiments, for melanoma imaging, the 
wavelength was set to 680 nm, where melanin absorbs much more strongly than blood. The 
optical fiber bundle and an ultrasound cable were incorporated into the same package with 
the linear transducer array. The beam incident angle was 30° with respect to the imaging 
plane. The optical fluence on the skin surface was estimated to be 10 mJ/cm2, which was 
less than the safety limit set by the American National Standard Institute (ANSI) (20 
mJ/cm2) at this wavelength. Each laser pulse generated a two-dimensional image. To get a 
3D PA image of the melanoma, the transducer array was scanned linearly along its 
elevational direction (x axis) by a motorized stage. An imaging station (Vevo LAZR, 
Visualsonics Inc.) displayed the photoacoustic images at five frames/second. The raw data 
was then exported to a computer for image reconstruction and analysis.
We first simulated and compared the single focused ultrasonic transducer described 
previously [6] with the array used in this paper. The simulation was conducted with the k-
space pseudo-spectral method [25], in which the acoustic wave equation was modeled and 
solved in k-space, utilizing the benefits of fast Fourier transformation. For the single focused 
ultrasonic transducer, the central frequency, bandwidth, focal length, and diameter were 25 
MHz, 100%, 12.7 mm, and 6.4 mm, respectively. The parameters of the array have been 
described above. Fig. 2(a) shows the melanoma mimicking target, a half disk with a radius 
of 2 mm. To form the image, we raster scanned the single focused ultrasonic transducer and 
combined the adjacent A-lines, while a time-reversal reconstruction method was used for the 
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array system. In the time reversal method, the received pressure data were used as boundary 
conditions and the acoustic waves were propagated in time-reversed order to find the 
pressure map at the initial time [26]. Fig. 2(b) shows that only the horizontal boundaries of 
the target are recovered by the single transducer based system. In contrast, almost the entire 
boundary of the target is recovered using the linear array for detection (Fig. 2c). In addition, 
because the linear array scan does not need to be performed, the imaging speed can be 
significantly improved.
The spatial resolution of the linear-array based PA probe was then quantified by imaging 
two crossed 6-μm-diameter carbon fibers, shown in Fig. 3(a-b). The carbon fibers were 
placed in the x-y plane at a distance of 9 mm from the surface of the linear transducer array. 
Figures 3(c)-(e) show both the fitting curves and PA amplitude distributions along the 
elevational (x), lateral (y), and axial (z) directions. The full width at half maximum 
(FWHM) values, which are also spatial resolutions, are 1237 μm, 119 μm, and 86 μm in the 
elevational, lateral, and axial directions, respectively [27].
Phantom experiments were then conducted to show the ability of the linear-array-based PA 
probe to measure melanoma thickness (depth) and calculate tumor volume (size). As shown 
in Fig. 4(a), melanoma phantoms of varying thicknesses and volumes were prepared. All the 
phantoms were made from a black ink and agar mixture, which had an absorption coefficient 
of 70 cm–1 at 680 nm, close to the actual typical melanoma absorption coefficient. To mimic 
human tissue, the background was made of an agar and intralipid mixture with a scattering 
coefficient around 100 cm–1 and a scattering anisotropy of ~0.9. To facilitate optimal 
comparison of melanoma phantoms, we took the maximum-amplitude-projections of the 3D 
PA images along the elevational direction of the linear array, as shown in Fig. 4(b1-b7). 
Immediately following the array-based experiments, melanoma phantoms were carefully 
removed from the agar/intralipid mixture, and corresponding gross images were taken using 
a standard microscope (EZ4 Stereo microscope, Leica), as shown in Fig. 4(c1-c7). There is 
an excellent correlation between the PA and gross images, demonstrating the ability of this 
system to accurately reproduce the phantom in situ. To further demonstrate the accuracy of 
the PA system and thus its potential for in vivo imaging, we then calculated both the depth 
and volume of these melanoma phantoms (Fig. 5). The thickness and volume of the 
melanoma phantoms measured by the standard microscope and a graduated cylinder, 
respectively, served as the gold standards. In the PA measurements, to quantify the depth, 
the 6 dB threshold was used to separate the melanoma from the background. To quantify the 
volume, the 3D melanoma images were first downsampled. The downsampled image pixel 
size was equal to the resolution in each direction. The downsampled images were then 
thresholded at 6 dB of the noise level to create melanoma boundaries. In the end, the volume 
was calculated by integrating the voxels inside the melanoma. We show that both the depths 
and volumes measured by our system agree well with the standard values, indicating that our 
linear-array-based PA probe can detect both the depth and volume of deeply seated 
melanoma in situ with high accuracy.
We then performed experiments ex vivo to determine the accuracy of our system for 
thickness (depth) measurement, and volume calculation. For these experiments, we used a 
murine xenograft model where B16 melanoma cells were subcutaneously injected into the 
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dorsal surface of nude mice (Hsd:Athymic Nude-Foxn1NU, Harlan Co.; average body 
weight: 20 g). All experimental animal procedures were carried out in conformity with the 
laboratory animal protocol approved by the Animal Studies Committee of Washington 
University in St. Louis. Tumors were allowed to grow spontaneously for 15 days, and the 
mice were then sacrificed. Fresh tumors excised from nude mice were embedded in the agar 
and intralipid mixture, prepared as described earlier (Fig. 6a). Imaging and processing was 
then performed as in the phantom experiments. Similarly, the ex vivo PA images of the 
melanomas are representative of the tumors as shown in Figs. 6(b) and (c). Again, the 
thickness and volume values calculated from the images are in accordance with the preset 
values (shown in Fig. 7). Thus, we conclude that our system should be able to accurately 
image deep melanomas in vivo.
Finally, we imaged mice with melanoma in vivo to show the detection ability of the linear-
array-based PA probe. We again employed the murine xenograft model using B16 
melanoma cells in nude mice. For image acquisition, mice were anesthetized and kept 
motionless using a breathing anesthesia system (E-Z Anesthesia, Euthanex), while body 
temperature was maintained by an electric heating pad. Each measurement was repeated at 
day 3 and day 6 following the injection of cells (Fig. 8a, b), and the rate of growth (ROG) 
was calculated. Again the detected melanoma can be clearly distinguished from the 
surrounding soft tissue. The depth and volume of the melanoma at day 3 and day 6 were 
measured to be 1.32 mm and 22.365 mm3, and 2.77 mm and 71.931 mm3, respectively. The 
depth-based and volume-based ROG were calculated to be 0.48 mm/day and 16.555 mm3/
day, respectively.
In sum, compared to our single ultrasonic transducer based system [6], the linear-array-
based system can detect melanoma with an order of magnitude increase in the imaging 
speed. In addition, because of the large acceptance angle of the linear ultrasonic transducer 
array, nearly the entire melanoma can be detected in 3D, as opposed to only the horizontal 
boundary. Employing this technology also enables the calculation of melanoma volume. We 
hypothesize that, similar to other solid tumors, determination of melanoma volume may 
represent a more accurate diagnostic and prognostic parameter than the currently used 
measurement of tumor thickness (Breslow's depth). Furthermore, the ability to determine 
melanoma volume also provides a more straightforward and accurate way to determine and 
quantify change in a pigmented lesion that may be indicative of malignancy. We recognize 
that this increased accuracy comes at a price, considering the cost differential between the 
array system and the single ultrasonic transducer system. Nevertheless, we are now well 
poised to apply this system in the clinic to determine whether we can reproduce our findings 
in patients with pigmented lesions and melanoma. We propose that the increased accuracy 
afforded by the array will translate into improved management of the melanoma patient. 
Although we focused on only pigmented lesion detection in this work, it is worth 
mentioning that unpigmented lesions can also be detected with the assistance of exogenous 
contrast, such as gold nanocages [28].
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Fig. 1. 
Schematic diagram of the LZ250 linear transducer array with optical fiber bundle integrated. 
(a) View from the elevational direction (x). (b) View of the transducer array's head (enclosed 
by a dashed box in (a)) from the lateral direction (y).
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Fig. 2. 
Simulation of the single focused ultrasonic transducer and the linear array. (a) Preset energy 
deposition distribution (Ae). Recovered Ae by the single focused ultrasonic transducer (b) 
and by the linear array transducer (c).
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Fig. 3. 
Response characteristics of the linear-array probe. (a) Maximum amplitude projection of the 
two crossed 6-μm-diameter carbon fibers. The diameters differ because of the directional 
resolution differences. (b) Cross-section image of the vertical carbon fiber along the dashed 
line in (a). Experimental data and Gaussian fits of the PA amplitude distributions along the 
(c) x, (d) y, and (e) z directions.
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Fig. 4. 
Linear-array-based PA images of melanoma phantoms. (a) Photo of the melanoma 
phantoms. (b1-b7) and (c1-c7) correspond to the melanoma phantoms 1-7 in (a). Melanoma 
phantom images acquired by PA (b1-b7) and a standard optical microscope (c1-c7).
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Fig. 5. 
Depth (a) and volume (b) quantification of melanoma phantoms. Blue dots: experimental 
measurements. Red lines: ideal line if the PA measurements are identical to the standard 
measurements.
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Fig. 6. 
Linear-array-based PA images of ex vivo melanomas. (a) A photo of the ex vivo melanomas. 
(b1-b6) and (c1-c6) correspond to the melanoma phantoms 1-6 in (a). Melanoma images 
acquired by PA (b1-b6) and a standard optical microscope (c1-c6).
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Fig. 7. 
Depth (a) and volume (b) quantification of ex vivo melanomas. Blue dots: experimental 
measurements. Red lines: ideal line if the PA measurements are identical to the standard 
measurements.
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Fig. 8. 
Linear-array-based PA images of melanoma acquired in vivo on day 3 (a) and day 6 (b).
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